Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Evolving medical therapies for ulcerative colitis.

P Y Chung1, R D Cohen

  • 1Department of Medicine, Section of Gastroenterology, The University of Chicago Medical Center, MC 4076, 5841 South Maryland Avenue, Chicago, IL 60637, USA.

Current Gastroenterology Reports
|November 7, 2001
PubMed
Summary

Ulcerative colitis treatments are evolving beyond traditional drugs. Novel therapies targeting the immune response, including biologics and less traditional options, offer new hope for patients with inflammatory bowel disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Incidence of meticillin-resistant Staphylococcus aureus contamination on mobile phones of medical students.

The Journal of hospital infection·2019
Same author

Crossroads in Medical Computing.

Journal of the Royal College of Physicians of London·2019
Same author

Video Feedback on Mother-child Interactions in Perinatal Psychiatric Service in Hong Kong.

East Asian archives of psychiatry : official journal of the Hong Kong College of Psychiatrists = Dong Ya jing shen ke xue zhi : Xianggang jing shen ke yi xue yuan qi kan·2018
Same author

Ketone bodies promote a rapid rise in glutamate efflux from the isolated perfused rat liver without altering the rate of glutamine production.

Amino acids·2013
Same author

A response.

Journal of the Royal Society of Medicine·2010
Same author

Systematic review: the costs of ulcerative colitis in Western countries.

Alimentary pharmacology & therapeutics·2010

Area of Science:

  • Gastroenterology and immunology
  • Inflammatory bowel disease research

Background:

  • Traditional ulcerative colitis (UC) therapies include sulfasalazine, mesalamine, and corticosteroids.
  • For steroid-refractory or intolerant patients, short-term options like cyclosporine and long-term agents like 6-mercaptopurine or azathioprine are used.

Purpose of the Study:

  • To review the evolving landscape of ulcerative colitis therapies.
  • To highlight novel agents targeting the immune response and explore non-traditional treatment approaches.

Main Methods:

  • Literature review of current and emerging ulcerative colitis treatments.
  • Analysis of therapies targeting tumor necrosis factor, interleukins, interferons, and T-cell pathways.
  • Inclusion of less traditional therapies like probiotics and heparins.

Related Experiment Videos

Main Results:

  • Novel agents targeting various immune response aspects are under investigation.
  • Biologic therapies, particularly those blocking tumor necrosis factor, show significant interest.
  • Emerging research includes T-cell selective antibodies, cellular trafficking molecules, and growth factors.

Conclusions:

  • The next generation of ulcerative colitis therapies involves a diverse range of immunomodulatory agents.
  • Novel and less traditional treatments may offer new insights into UC pathogenesis and management.
  • Future UC treatment strategies are expanding beyond conventional medical therapy.